TRUBRIDGE INC (TBRG) Stock Fundamental Analysis
NASDAQ:TBRG - Nasdaq - US2053061030 - Common Stock - Currency: USD
Overall TBRG gets a fundamental rating of 4 out of 10. We evaluated TBRG against 37 industry peers in the Health Care Technology industry. TBRG has a medium profitability rating, but doesn't score so well on its financial health evaluation. TBRG is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year TBRG was profitable.
In the past year TBRG had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: TBRG reported negative net income in multiple years.
Each year in the past 5 years TBRG had a positive operating cash flow.
1.2 Ratios
The Return On Assets of TBRG (-5.61%) is better than 70.27% of its industry peers.
TBRG's Return On Equity of -13.11% is fine compared to the rest of the industry. TBRG outperforms 64.86% of its industry peers.
TBRG's Return On Invested Capital of 1.20% is fine compared to the rest of the industry. TBRG outperforms 75.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.61% | ||
| ROE | -13.11% | ||
| ROIC | 1.2% |
ROA(3y)-3.89%
ROA(5y)-0.55%
ROE(3y)-9.64%
ROE(5y)-2.79%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a decent Operating Margin value of 1.22%, TBRG is doing good in the industry, outperforming 72.97% of the companies in the same industry.
TBRG's Operating Margin has declined in the last couple of years.
TBRG has a Gross Margin (50.62%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of TBRG has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.22% | ||
| PM (TTM) | N/A | ||
| GM | 50.62% |
OM growth 3Y-40.35%
OM growth 5Y-26.39%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.4%
GM growth 5Y-0.64%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TBRG is destroying value.
The number of shares outstanding for TBRG has been increased compared to 1 year ago.
Compared to 5 years ago, TBRG has more shares outstanding
The debt/assets ratio for TBRG has been reduced compared to a year ago.
2.2 Solvency
TBRG has an Altman-Z score of 2.14. This is not the best score and indicates that TBRG is in the grey zone with still only limited risk for bankruptcy at the moment.
TBRG has a Altman-Z score of 2.14. This is in the better half of the industry: TBRG outperforms 64.86% of its industry peers.
TBRG has a debt to FCF ratio of 13.20. This is a negative value and a sign of low solvency as TBRG would need 13.20 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 13.20, TBRG is in line with its industry, outperforming 56.76% of the companies in the same industry.
A Debt/Equity ratio of 1.00 indicates that TBRG is somewhat dependend on debt financing.
TBRG has a worse Debt to Equity ratio (1.00) than 75.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1 | ||
| Debt/FCF | 13.2 | ||
| Altman-Z | 2.14 |
ROIC/WACC0.11
WACC11.11%
2.3 Liquidity
A Current Ratio of 1.70 indicates that TBRG should not have too much problems paying its short term obligations.
The Current ratio of TBRG (1.70) is comparable to the rest of the industry.
TBRG has a Quick Ratio of 1.69. This is a normal value and indicates that TBRG is financially healthy and should not expect problems in meeting its short term obligations.
TBRG has a Quick ratio of 1.69. This is comparable to the rest of the industry: TBRG outperforms 54.05% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.7 | ||
| Quick Ratio | 1.69 |
3. Growth
3.1 Past
TBRG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -74.29%.
Measured over the past years, TBRG shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -40.46% on average per year.
The Revenue has been growing slightly by 0.95% in the past year.
Measured over the past years, TBRG shows a small growth in Revenue. The Revenue has been growing by 4.53% on average per year.
EPS 1Y (TTM)-74.29%
EPS 3Y-58.61%
EPS 5Y-40.46%
EPS Q2Q%89.47%
Revenue 1Y (TTM)0.95%
Revenue growth 3Y6.89%
Revenue growth 5Y4.53%
Sales Q2Q%4.76%
3.2 Future
Based on estimates for the next years, TBRG will show a very strong growth in Earnings Per Share. The EPS will grow by 201.88% on average per year.
TBRG is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.30% yearly.
EPS Next Y636.82%
EPS Next 2Y201.88%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.15%
Revenue Next 2Y5.3%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
TBRG is valuated quite expensively with a Price/Earnings ratio of 65.81.
Based on the Price/Earnings ratio, TBRG is valued a bit cheaper than 70.27% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 25.91, TBRG is valued quite expensively.
Based on the Price/Forward Earnings ratio of 13.68, the valuation of TBRG can be described as correct.
TBRG's Price/Forward Earnings ratio is rather cheap when compared to the industry. TBRG is cheaper than 86.49% of the companies in the same industry.
TBRG is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.85, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 65.81 | ||
| Fwd PE | 13.68 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, TBRG is valued cheaply inside the industry as 81.08% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, TBRG is valued cheaper than 83.78% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 27.26 | ||
| EV/EBITDA | 15.24 |
4.3 Compensation for Growth
TBRG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
TBRG's earnings are expected to grow with 201.88% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.1
PEG (5Y)N/A
EPS Next 2Y201.88%
EPS Next 3YN/A
5. Dividend
5.1 Amount
TBRG does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
23.69
-0.46 (-1.9%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners74.28%
Inst Owner Change0%
Ins Owners2.34%
Ins Owner Change12.26%
Market Cap354.17M
Analysts78
Price Target29.84 (25.96%)
Short Float %6.75%
Short Ratio4.59
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-131.78%
Min EPS beat(2)-176.25%
Max EPS beat(2)-87.3%
EPS beat(4)1
Avg EPS beat(4)-61.77%
Min EPS beat(4)-176.25%
Max EPS beat(4)24.18%
EPS beat(8)3
Avg EPS beat(8)-36.59%
EPS beat(12)5
Avg EPS beat(12)-24.75%
EPS beat(16)8
Avg EPS beat(16)-14.99%
Revenue beat(2)1
Avg Revenue beat(2)0.34%
Min Revenue beat(2)-0.82%
Max Revenue beat(2)1.51%
Revenue beat(4)2
Avg Revenue beat(4)-0.02%
Min Revenue beat(4)-1.68%
Max Revenue beat(4)1.51%
Revenue beat(8)2
Avg Revenue beat(8)-1.22%
Revenue beat(12)4
Avg Revenue beat(12)-0.49%
Revenue beat(16)6
Avg Revenue beat(16)-0.42%
PT rev (1m)0.17%
PT rev (3m)46.25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.63%
EPS NY rev (1m)0.18%
EPS NY rev (3m)-12.36%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.57%
Revenue NY rev (1m)0.28%
Revenue NY rev (3m)-0.86%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 65.81 | ||
| Fwd PE | 13.68 | ||
| P/S | 0.83 | ||
| P/FCF | 27.26 | ||
| P/OCF | 11.04 | ||
| P/B | 2.1 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.24 |
EPS(TTM)0.36
EY1.52%
EPS(NY)1.73
Fwd EY7.31%
FCF(TTM)0.87
FCFY3.67%
OCF(TTM)2.15
OCFY9.06%
SpS28.49
BVpS11.28
TBVpS-8.16
PEG (NY)0.1
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.61% | ||
| ROE | -13.11% | ||
| ROCE | 1.52% | ||
| ROIC | 1.2% | ||
| ROICexc | 1.24% | ||
| ROICexgc | 10.66% | ||
| OM | 1.22% | ||
| PM (TTM) | N/A | ||
| GM | 50.62% | ||
| FCFM | 3.05% |
ROA(3y)-3.89%
ROA(5y)-0.55%
ROE(3y)-9.64%
ROE(5y)-2.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-34.77%
ROICexcg growth 5Y-16.72%
ROICexc growth 3Y-36.47%
ROICexc growth 5Y-24.96%
OM growth 3Y-40.35%
OM growth 5Y-26.39%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.4%
GM growth 5Y-0.64%
F-Score7
Asset Turnover1.08
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1 | ||
| Debt/FCF | 13.2 | ||
| Debt/EBITDA | 4.94 | ||
| Cap/Depr | 65.92% | ||
| Cap/Sales | 4.48% | ||
| Interest Coverage | 0.32 | ||
| Cash Conversion | 93.98% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.7 | ||
| Quick Ratio | 1.69 | ||
| Altman-Z | 2.14 |
F-Score7
WACC11.11%
ROIC/WACC0.11
Cap/Depr(3y)79.13%
Cap/Depr(5y)69.66%
Cap/Sales(3y)6.13%
Cap/Sales(5y)4.92%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-74.29%
EPS 3Y-58.61%
EPS 5Y-40.46%
EPS Q2Q%89.47%
EPS Next Y636.82%
EPS Next 2Y201.88%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.95%
Revenue growth 3Y6.89%
Revenue growth 5Y4.53%
Sales Q2Q%4.76%
Revenue Next Year5.15%
Revenue Next 2Y5.3%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y219.12%
EBIT growth 3Y-36.24%
EBIT growth 5Y-23.05%
EBIT Next Year147.19%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y158.15%
FCF growth 3Y-29.73%
FCF growth 5Y-20.85%
OCF growth 1Y2930.59%
OCF growth 3Y-12.4%
OCF growth 5Y-5.94%